Centene Corporation (NYSE:CNC) Director Robert K. Ditmore sold 8,750 shares of Centene stock in a transaction dated Monday, January 8th. The shares were sold at an average price of $104.30, for a total transaction of $912,625.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
Robert K. Ditmore also recently made the following trade(s):
- On Thursday, October 26th, Robert K. Ditmore sold 4,167 shares of Centene stock. The shares were sold at an average price of $90.42, for a total transaction of $376,780.14.
Shares of Centene Corporation (CNC) traded down $2.98 on Friday, reaching $103.75. 1,200,000 shares of the company’s stock were exchanged, compared to its average volume of 1,140,000. The company has a current ratio of 0.99, a quick ratio of 0.99 and a debt-to-equity ratio of 0.71. The firm has a market capitalization of $17,900.00, a PE ratio of 21.44, a P/E/G ratio of 1.32 and a beta of 0.71. Centene Corporation has a one year low of $63.12 and a one year high of $112.42.
Several brokerages have recently weighed in on CNC. ValuEngine raised shares of Centene from a “hold” rating to a “buy” rating in a report on Friday. BMO Capital Markets initiated coverage on shares of Centene in a research note on Tuesday, October 17th. They issued an “outperform” rating and a $120.00 price objective for the company. Oppenheimer reiterated a “buy” rating and issued a $105.00 price objective on shares of Centene in a research note on Tuesday, October 24th. Goldman Sachs Group initiated coverage on shares of Centene in a research note on Wednesday, January 3rd. They issued a “buy” rating and a $135.00 price objective for the company. Finally, Cantor Fitzgerald reiterated a “buy” rating and issued a $107.00 price objective on shares of Centene in a research note on Tuesday, October 24th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, seventeen have issued a buy rating and one has issued a strong buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average price target of $104.21.
Institutional investors and hedge funds have recently made changes to their positions in the business. Columbus Circle Investors acquired a new position in Centene during the third quarter worth about $9,387,000. Arrowstreet Capital Limited Partnership acquired a new position in Centene during the second quarter worth about $455,000. Handelsbanken Fonder AB raised its position in Centene by 29.0% during the third quarter. Handelsbanken Fonder AB now owns 178,000 shares of the company’s stock worth $17,225,000 after acquiring an additional 40,000 shares during the last quarter. Trustmark National Bank Trust Department acquired a new position in Centene during the third quarter worth about $291,000. Finally, Allen Investment Management LLC acquired a new position in Centene during the third quarter worth about $327,000. Institutional investors own 92.33% of the company’s stock.
TRADEMARK VIOLATION NOTICE: “Insider Selling: Centene Corporation (NYSE:CNC) Director Sells 8,750 Shares of Stock” was reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this news story on another domain, it was illegally stolen and reposted in violation of U.S. & international copyright & trademark laws. The original version of this news story can be accessed at https://www.dispatchtribunal.com/2018/02/03/centene-corporation-cnc-director-sells-912625-00-in-stock.html.
Centene Company Profile
Centene Corporation is a healthcare company. The Company provides a portfolio of services to government sponsored healthcare programs, focusing on under-insured and uninsured individuals. The Company operates through two segments: Managed Care and Specialty Services. The Company’s Managed Care segment provides health plan coverage to individuals, through government subsidized programs, including Medicaid, the State Children’s Health Insurance Program (CHIP), Long Term Care, Foster Care, dual-eligible individuals (Duals) and the Supplemental Security Income Program, also known as the Aged, Blind or Disabled Program (ABD), Medicare, and Health Insurance Marketplace.
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.